TetraGenetics Competitors and Similar CompaniesClear all
TetraGenetics's competitors and similar companies include Organogenesis, JPT Peptide Technologies, Tango Therapeutics and Biosynth Netherlands.
 TetraGenetics TetraGenetics is a biotech company focused on the discovery of novel therapeutics for autoimmune disease and pain. |  Organogenesis Organogenesis is a leader in regenerative medicine, specializing in bio-active wound healing and oral regeneration. |  JPT Peptide Technologies JPT Peptide Technologies is a biotech company that develops peptide-based products. |  Tango Therapeutics Tango Therapeutics is a biotech company develops transformational cancer treatments. |  Biosynth Netherlands Biosynth Netherlands (formerly known as Pepscan Holding) is a company that provides custom peptide-based products, including peptide synthesis, epitope mapping, peptide arrays, and immunology and antibody services. | |
Founding Date | Founding Date 2004 | Founding Date 1985 | Founding Date 2004 | Founding Date 2017 | Founding Date 2000 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Arlington, US HQ | Locations Canton, US HQ Kanton Reinach, CH Canton, US San Diego, US | Locations Berlin, DE HQ | Locations Cambridge, US HQ | Locations Lelystad, NL HQ |
Employees | Employees 17 | Employees 9791% decrease | Employees 721% decrease | Employees 1481% increase | Employees 383% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 395.1 m | Valuation ($) N/A | Valuation ($) 642.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $564.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $62.4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income $37m (FY, 2025) | Net income N/A | Net income ($101.6m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
ISO Certifications | ISO Certifications N/A | ISO Certifications N/A | ISO Certifications 1 (Apr, 2024) | ISO Certifications N/A | ISO Certifications 1 (Jun, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 5.3m | Total funding raised $ 75m | Total funding raised N/A | Total funding raised $ 165m | Total funding raised $ 14.8m |
For sources of this data, please see the company profile
View Company Profiles
Organogenesis
HQ
Canton, US
Employees
979↓ 1% decrease
Organogenesis is a leader in regenerative medicine, specializing in bio-active wound healing and oral regeneration.
View companyJPT Peptide Technologies
HQ
Berlin, DE
JPT Peptide Technologies is a biotech company that develops peptide-based products.
View companyTango Therapeutics
HQ
Cambridge, US
Employees
148↑ 1% increase
Tango Therapeutics is a biotech company develops transformational cancer treatments.
View companyBiosynth Netherlands
HQ
Lelystad, NL
Biosynth Netherlands (formerly known as Pepscan Holding) is a company that provides custom peptide-based products, including peptide synthesis, epitope mapping, peptide arrays, and immunology and antibody services.
View company